OLD Category: panels

A Phase 0 Trial of Ribociclib in Recurrent Glioblastoma Patients Incorporating a Tumor Pharmacodynamic- and Pharmacokinetic-Guided Expansion Cohort

• Tien AC et al.,

A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor

• Sin-Chan P et al.,

A tumor‐targeting nanomedicine carrying the p53 gene crosses the blood–brain barrier and enhances anti‐PD‐1 immunotherapy in mouse models of glioblastoma

• Kim SS et al.,

Transcription factor Oct1 protects against hematopoietic stress and promotes acute myeloid leukemia

• Jafek JL et al.,

Immune function as predictor of infectious complications and clinical outcome in patients undergoing solid organ transplantation (the ImmuneMo:SOT study): a prospective non-interventional observational trial

• Drabe CH et al.,

Reproduction of molecular subtypes of gastric adenocarcinoma by transcriptome sequencing of archival tissue

• Heo YJ et al.,

Circadian variation in pulmonary inflammatory responses is independent of rhythmic glucocorticoid signaling in airway epithelial cells

• Ince LM et al.,

mTORC2 Deficiency Alters the Metabolic Profile of Conventional Dendritic Cells

• Watson AR et al.,

MERTK acts as a costimulatory receptor on human CD8+ T cells

• Peeters MJW et al.,

Methods for Identifying Patients with Tropomyosin Receptor Kinase (TRK) Fusion Cancer

• Wong D, Yip S, Sorensen PH

Large-scale dissection suggests that ultraconserved elements are dispensable for mouse embryonic stem cell survival and fitness

• Schneider A et al.,

Brain-resident memory T cells generated early in life predispose to autoimmune disease in mice

• Steinbach K et al.,